PL2421508T3 - Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych - Google Patents

Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych

Info

Publication number
PL2421508T3
PL2421508T3 PL10716464T PL10716464T PL2421508T3 PL 2421508 T3 PL2421508 T3 PL 2421508T3 PL 10716464 T PL10716464 T PL 10716464T PL 10716464 T PL10716464 T PL 10716464T PL 2421508 T3 PL2421508 T3 PL 2421508T3
Authority
PL
Poland
Prior art keywords
active ingredients
controlled release
particulate material
particulate
release
Prior art date
Application number
PL10716464T
Other languages
English (en)
Inventor
Kurt Møller Pedersen
Jette Baek Andersen
Original Assignee
Omya International Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42289647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2421508(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omya International Ag filed Critical Omya International Ag
Publication of PL2421508T3 publication Critical patent/PL2421508T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/064—Chewing gum characterised by the composition containing organic or inorganic compounds containing inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
PL10716464T 2009-04-24 2010-04-26 Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych PL2421508T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17247409P 2009-04-24 2009-04-24

Publications (1)

Publication Number Publication Date
PL2421508T3 true PL2421508T3 (pl) 2017-06-30

Family

ID=42289647

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10716464T PL2421508T3 (pl) 2009-04-24 2010-04-26 Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych

Country Status (13)

Country Link
US (2) US20120321751A1 (pl)
EP (2) EP2421507B1 (pl)
JP (1) JP5732043B2 (pl)
KR (2) KR101775169B1 (pl)
CN (1) CN102481257B (pl)
AU (1) AU2010238945B2 (pl)
CA (1) CA2758618C (pl)
CL (1) CL2011002627A1 (pl)
DK (1) DK2421508T3 (pl)
ES (1) ES2619556T3 (pl)
PL (1) PL2421508T3 (pl)
RU (1) RU2530655C2 (pl)
WO (2) WO2010121620A1 (pl)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168572A1 (en) 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
GB0911402D0 (en) * 2009-07-01 2009-08-12 Brightwake Ltd Propolis film
EP2557947A1 (en) 2010-04-14 2013-02-20 Altria Client Services Inc. Preformed smokeless tobacco product
KR20130030260A (ko) 2010-05-10 2013-03-26 유로-셀티큐 에스.에이. 히드로모르폰 및 날록손을 포함하는 제약 조성물
NZ603173A (en) 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
WO2011141490A1 (en) 2010-05-10 2011-11-17 Euro-Celtique S.A. Combination of active loaded granules with additional actives
JP2014506894A (ja) * 2011-02-28 2014-03-20 テクノロジーズ・クロロス・インク 口腔吸収用の咀嚼可能なビヒクル
US9357801B2 (en) 2011-10-19 2016-06-07 Fertin Pharma A/S Nicotine chewing gum with improved utilization of nicotine
EP3075376A1 (en) 2011-11-10 2016-10-05 Omya International AG New coated controlled release active agent carriers
TWI625129B (zh) 2011-11-10 2018-06-01 歐米亞國際公司 新穎的經塗布控釋活性劑載體
EP2793849A1 (en) * 2011-12-22 2014-10-29 Fertin Pharma A/S Method of releasing nicotine from chewing gum
SE536491C2 (sv) * 2012-03-26 2013-12-27 Bionicotine Ab Påse innehållande nikotin och en tuggummikomposition
EP2653042A1 (en) * 2012-04-20 2013-10-23 JT International SA pH-stabilized oral tobacco composition
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
KR102705152B1 (ko) 2013-05-06 2024-09-09 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
KR102957402B1 (ko) 2013-12-05 2026-04-24 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 액제 및 그 방법
US10426726B2 (en) 2014-04-08 2019-10-01 Fertin Pharma A/S Medical chewing gum
AR101774A1 (es) * 2014-09-12 2017-01-11 Wrigley W M Jun Co Composición de goma de mascar que comprenden varios edulcorantes
WO2016095083A1 (en) 2014-12-15 2016-06-23 Colgate-Palmolive Company High salt toothpaste and methods for using same
JP6479464B2 (ja) * 2014-12-26 2019-03-06 三栄源エフ・エフ・アイ株式会社 チューインガムからのアドバンテームの甘味の発現を調整する方法
CN105029676A (zh) * 2015-08-31 2015-11-11 湖北中烟工业有限责任公司 一种抗牙齿过敏的嚼烟
WO2017053970A1 (en) 2015-09-24 2017-03-30 The Brigham And Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
US10485247B2 (en) 2015-10-07 2019-11-26 Fertin Pharma A/S Chewing gum comprising nicotine
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3192850B1 (en) 2016-01-14 2018-10-03 Omya International AG Use of surface-treated calcium carbonate as oxygen scavenger
EP3192838A1 (en) * 2016-01-14 2017-07-19 Omya International AG Treatment of surface-reacted calcium carbonate
CN105795087B (zh) * 2016-05-05 2023-04-11 宜兰食品工业股份有限公司 一种压片糖果及其制备方法
EP3275947A1 (en) 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
JP2019523275A (ja) 2016-07-26 2019-08-22 アナンド パラチュル，ヴィヴェク 有効成分の徐放性組成物
CN106361768A (zh) * 2016-08-29 2017-02-01 宋延军 一种用于辅助治疗高血压、糖尿病的组合物及其制剂
MX378387B (es) * 2017-02-21 2025-03-10 Colgate Palmolive Co Composiciones para el cuidado bucal y metodos de uso
EP3378502A1 (en) * 2017-03-23 2018-09-26 Omya International AG Use of zinc treated precipitated calcium carbonate in hygienic products
KR102638408B1 (ko) * 2017-05-24 2024-02-21 필립모리스 프로덕츠 에스.에이. 염기성 ph 조절제를 포함하는 균질화된 식물 재료
SE541358C2 (en) * 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
PL3641726T3 (pl) 2017-06-23 2026-02-23 Nordiccan A/S Woreczek z kannabinoidami
WO2018233795A1 (en) 2017-06-23 2018-12-27 Fertin Pharma A/S Nicotine pouch
EP3594289A1 (en) * 2018-07-13 2020-01-15 Omya International AG Surface-reacted calcium carbonate for stabilizing mint oil
WO2020012009A1 (en) * 2018-07-13 2020-01-16 Mcneil Ab Chewing gum comprising nicotine
CN111419462A (zh) * 2019-01-09 2020-07-17 曹荣华 一种口腔保健用品
CN110202860B (zh) * 2019-05-31 2021-04-23 华南农业大学 一种梯度缓释型的活性复合膜及其制备方法
GB2584649A (en) * 2019-06-06 2020-12-16 Pa Knowledge Ltd Infusion product and method of making an infusion product
DK3826477T3 (da) 2019-06-07 2023-12-11 Philip Morris Products Sa Poseprodukt med flydende smagssammensætning
DK180339B1 (en) 2019-06-07 2020-12-18 Ncp Nextgen As Nicotine pouch composition and pouch comprising such
US20220248707A1 (en) * 2019-07-16 2022-08-11 Advanced Female Technologies Llc Chewing gum compositions for the treatment of menopausal symptoms
US11759419B2 (en) 2019-10-11 2023-09-19 Fertin Pharma A/S Compressed nicotine lozenge
US20210106516A1 (en) * 2019-10-11 2021-04-15 Fertin Pharma A/S Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11672862B2 (en) * 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
JP2023505351A (ja) * 2019-12-09 2023-02-08 ニコベンチャーズ トレーディング リミテッド 口腔用組成物のための薬剤
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US20220304366A1 (en) * 2019-12-09 2022-09-29 Nicoventures Trading Limited Oral products with reduced irritation
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
CN111227427A (zh) * 2020-01-16 2020-06-05 浙江荣威鞋业有限公司 一种鞋底抗菌的鞋子及其制备工艺
WO2021231860A1 (en) * 2020-05-14 2021-11-18 Primo Pharmatech Llc Solid dosage form for transmucosal drug delivery
CN111558033A (zh) * 2020-05-14 2020-08-21 广州中昱医学生物科技有限公司 一种口腔清洁组合物及其应用
EP4243796A4 (en) * 2020-11-16 2025-01-22 Orcosa Inc. IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
WO2022269556A1 (en) 2021-06-25 2022-12-29 Nicoventures Trading Limited Oral products and method of manufacture
US20230148652A1 (en) * 2021-11-15 2023-05-18 Nicoventures Trading Limited Oral products with nicotine-polymer complex
CN114532587B (zh) * 2022-01-12 2023-06-30 云南中烟工业有限责任公司 一种可调控缓释性能的改性Al2O3/香料复合材料的制备方法及其应用
US12121047B2 (en) 2022-06-14 2024-10-22 Botany Al, Inc. Dynamically delivering fat and flavor potentiators to foods and methods of use thereof
WO2023245070A2 (en) * 2022-06-14 2023-12-21 BOTANY AL, INC., dba UMMINO Dynamically delivering fat and flavor potentiators to foods and methods of use thereof
WO2024258969A2 (en) * 2023-06-15 2024-12-19 Botany AI, Inc., dba Ummino Dynamically delivering fat and flavor potentiators to foods and methods of use thereof
CN116725220A (zh) * 2023-06-16 2023-09-12 东莞市吉纯生物技术有限公司 一种以壳聚糖为基质的尼古丁口含制品及其制备方法
DK182139B1 (en) 2023-09-29 2025-09-04 Fertin Pharma As Nicotine pouch comprising particulate inorganic mineral filler

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1171392A (en) * 1913-10-09 1916-02-08 Adolphus G Meier Chewing-gum and method of making the same.
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS5964527A (ja) * 1982-09-29 1984-04-12 Shiraishi Chuo Kenkyusho:Kk アモルファス炭酸カルシウムの製造方法
US4656039A (en) * 1985-07-11 1987-04-07 Nabisco Brands, Inc. Layered chewing gum with moisture impervious outer layer
US4753800A (en) 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
WO1991015941A1 (en) * 1991-06-19 1991-10-31 Wm. Wrigley Jr. Company Chewing gum containing palatinose
US5399365A (en) * 1991-06-19 1995-03-21 Wm. Wrigley Jr. Company Chewing gum containing palatinose and/or palatinose oligosaccharide
JP3634404B2 (ja) * 1993-12-14 2005-03-30 丸尾カルシウム株式会社 多孔質炭酸カルシウム化合物及びその製造方法
US5556652A (en) * 1994-08-05 1996-09-17 Fuisz Technologies Ltd. Comestibles containing stabilized highly odorous flavor component delivery systems
KR0182788B1 (ko) * 1996-02-02 1999-04-15 유규재 초미세 교질 탄산칼슘의 제조방법
JP4110235B2 (ja) * 1996-12-25 2008-07-02 丸尾カルシウム株式会社 徐放体用花弁状多孔質基材及び徐放体組成物
MY114945A (en) * 1997-04-24 2003-02-28 Sunstar Inc Oral composition
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6344222B1 (en) * 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6541048B2 (en) * 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US20020004083A1 (en) * 1999-12-30 2002-01-10 Wm. Wrigley Jr. Company Controlled release perillartine in chewing gum
US6555145B1 (en) * 2000-06-06 2003-04-29 Capricorn Pharma, Inc. Alternate encapsulation process and products produced therefrom
JP3775569B2 (ja) * 2000-11-20 2006-05-17 有限会社ニューライム研究社 合成炭酸カルシウム系球状多孔質造粒体及びその製造方法
ES2321721T3 (es) * 2003-09-08 2009-06-10 Mcneil Ab Formulaciones de nicotina y uso de las mismas.
US20050084551A1 (en) * 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US7211275B2 (en) * 2004-01-16 2007-05-01 Massachusetts Institute Of Technology Composite materials for controlled release of water soluble products
AU2004323874A1 (en) * 2004-10-08 2006-04-13 Gumlink A/S Confectionery product
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
ES2349828T3 (es) * 2006-10-31 2011-01-11 Wm. Wrigley Jr., Company Núcleos de liberación de aromas para su uso en goma de mascar.
EP1974807B1 (en) * 2007-03-21 2010-03-03 Omya Development Ag Process for the removal of endocrine disrupting compounds
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier

Also Published As

Publication number Publication date
JP5732043B2 (ja) 2015-06-10
AU2010238945A1 (en) 2011-11-10
KR20170081748A (ko) 2017-07-12
WO2010121619A1 (en) 2010-10-28
ES2619556T3 (es) 2017-06-26
WO2010121620A1 (en) 2010-10-28
CA2758618A1 (en) 2010-10-28
KR101775169B1 (ko) 2017-09-05
KR20120023690A (ko) 2012-03-13
EP2421507A1 (en) 2012-02-29
CL2011002627A1 (es) 2012-07-06
JP2012524734A (ja) 2012-10-18
US20120321751A1 (en) 2012-12-20
CN102481257A (zh) 2012-05-30
CA2758618C (en) 2017-03-28
RU2530655C2 (ru) 2014-10-10
EP2421508B1 (en) 2016-12-14
RU2011147588A (ru) 2013-05-27
EP2421508A1 (en) 2012-02-29
US20120039981A1 (en) 2012-02-16
DK2421508T3 (en) 2017-03-27
EP2421507B1 (en) 2019-01-23
CN102481257B (zh) 2014-08-13
AU2010238945B2 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
IL214624A0 (en) Controlled release pharmaceutical formulations of nitazoxanide
ZA201208336B (en) Controlled release pharmaceutical compositions of tapentadol
ZA201008882B (en) Controlled release of microbiocides
AP2013006656A0 (en) Compositions for sustained release of agriculturalmacronutrients and process thereof
GB0905507D0 (en) Organopol Ysiloxane Compositions Containing An Active Material
ZA201207552B (en) Microporous material
SG10201600803SA (en) Methods and compositions for highly specific capture and release of biological materials
PL2554168T3 (pl) Kompozycja farmaceutyczna do kontrolowanego uwalniania
ZA201204583B (en) Degradable removable implant for the sustained release of an active compound
GB0912177D0 (en) Contained transfer of material
GB2467838B (en) Means for distribution of fish
ZA201205988B (en) Plant disease controlling composition and method for controlling plant disease
PL2542072T3 (pl) Kompozycja do zwalczania chorób roślin i sposób zwalczania chorób roślin
HU1000407D0 (en) Ph dependent spaced pharmaceutical composition of modified release
PL2415463T3 (pl) Kompozycja lecznicza w postaci cząstek stałych
LT2704698T (lt) Vaisto forma, skirta aktyvių ingredientų kontroliuojamam atpalaidavimui
HUE037915T2 (hu) Gyógyszerészeti készítmények aktív vegyületek felszabadítására
ZA201304511B (en) An implant for the controlled release of pharmaceutically active agents
ZA201201533B (en) Diminution of particulate material
ZA201301903B (en) Plant disease controlling composition and method for controlling plant disease
EP2467375A4 (en) FORMS OF DEXLANDSOPRAZOLE AND METHOD OF MANUFACTURING THEREOF
ZA201301904B (en) Plant disease controlling composition and method for controlling plant disease
SI2595939T1 (sl) Erodibilno keramično telo
HU1000224D0 (en) Pharmaceutical composition of controlled release
GB0910846D0 (en) Method of making particulate material